Therefore, we propose that downregulation or pharmacologic inhibition of DYRK3, CAMKV, and AKT1S1 in NB cells results in an impairment of the mitotic spindle organization and subsequent exit from the cell cycle, a function that will be the focus of future work. Here, DYRK3 is linked to neuroblastoma.